It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: Metallicus
Great OP! I am sure big pharma is proud of you and pleased that your conditioning has taken so well. Unless it costs big dollars it can't work, right?
"It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines. I take no pleasure in this conclusion, which I reached slowly and reluctantly over my two decades as an editor of The New England Journal of Medicine." -Marcia Angell, MD ("Drug Companies and Doctors: A story of Corruption." NY Review of Books, Jan. 15, 2009.)
originally posted by: Night Star
I had survived breast cancer. I had two kinds of breast cancer and one was aggressive. I too went the traditional route and had an awesome team of Doctors and Nurses. They cared not only for my physical problems but was interested in my emotional well being as well. That was a few years ago and so far I'm still here.
I once thought I would take a natural approach if I ever got cancer, but it's quite a different story when you are actually sitting in some office with a Doctor telling you that you have aggressive cancer.
What gets me is when someone will come right out and tell others that if they go the traditional route of chemo and radiation they will die. That is so ridiculous. There are people who have survived twenty and thirty years having had traditional treatments.
During the consultations, information given to patients about survival benefit included numerical data (“about four weeks”), an idea of timescales (“a few months extra”), vague references (“buy you some time”), or no mention at all. In most consultations (26/37) discussion of survival benefit was vague or non-existent
The search for effective treatments continues but, at the advanced stages of cancer, survival gain from palliative chemotherapy tends to be months rather than years. Statistics relating to survival benefit can be contested, prompting concerns among clinicians about how patients can make informed decisions if experts do not agree among themselves.19 Furthermore, there are concerns that the “intrusiveness of unfavourable numbers” can undermine healthcare relationships and destroy hope.2